Table 4.
Dependent variable: DAS28 at 2-years | ||||
---|---|---|---|---|
| ||||
b | 95% CI | Beta | p | |
DMARDs: % prescribed dose taken | −0.02 | −0.03, −0.001 | −0.2 | 0.03* |
Age | 0.02 | −0.01, 0.05 | 0.15 | 0.13 |
Female | 1.45 | 0.75, 2.15 | 0.37 | <0.01* |
Disease duration (years) | −0.05 | −0.1, −0.006 | −0.21 | 0.03* |
Cumulative dose of prednisone (grams) | 0.04 | −0.07, 0.15 | 0.07 | 0.5 |
Received biologics agents | 0.53 | −0.04, 1.09 | 0.18 | 0.07 |
Number of DMARDs used | 0.02 | −0.32, 0.36 | 0.01 | 0.90 |
Baseline DAS28 | 0.31 | 0.14, 0.49 | 0.33 | <0.01* |
Intercept | −0.2 | 0.87 | ||
| ||||
R2=0.44 |
CI= Confidence Interval; DMARD = disease-modifying antirheumatic drug; DAS28 = disease activity score 28-joint index
statistically significant.